Articulus Bio to Present at 6th Annual Venture Summit West Investor Conference

Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 6th Annual Venture Summit West investor conference on Wednesday, March 14, 2018, at 10:00 a.m. PST. The conference is being held at the Santa Clara Convention Center in Santa Clara, California.

The presentation will be webcast live and may be accessed by visiting the “Investors & Media” section of the Company’s website at A replay of the webcast will be available for 90 days.

About Venture Summit West

The 6th Annual Venture Summit West, presented by youngStartup Ventures, is the premiere industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers. For more information please visit

About Articulus Bio, LLC

Articulus Bio, LLC is a development-stage orthopedic medical device platform focused on total joint replacement. Our novel Tendonoid™ Web Joint technology addresses the problem at the heart of total joint replacement failures: polyethylene particulate wear debris. Poly-wear shedding occurs at articulating faces of the appliances caused by grinding, sliding and friction from natural anatomical motion. The Articulus Bio Tendonoid™ Web Joint technology engineers out the friction inducing grinding and sliding thereby eliminating wear debris. In addition, personalized 3D print geometries, customized jigs, individualized ranges of motion, and proven surfacing techniques all contribute to improved bone/device bond integrity, reduced bone/blood loss, improved surgical positioning and decreased OR time. Pipeline product candidates include total ankle replacement, cervical and lumbar artificial spine discs. For more information please visit


Go Back